An Argument for the Development of Ultra-Localized Antibiograms for Resistant Pathogens

Abstract

The importance of intensive care unit (ICU)–specific antibiograms has not been well established but may have key patient care implications if resistance rates are significantly different between the institution and a specific ICU location. Here, we argue that institutions should investigate and develop ultra-localized antibiograms for each ICU, especially for multi-drug resistant organisms.